Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

Immune checkpoint inhibitors (ICIs) have been introduced in breast cancer (BC) treatment and better biomarkers are needed to predict benefit. Circulating tumor cells (CTCs) are prognostic in BC, but knowledge is limited on CTCs in the context of ICI therapy. In this study, serial sampling of CTCs (C...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Elin Borgen, Cecilie Bendigtsen Schirmer, Bjørnar Gilje, Øystein Garred, Jon Lømo, Marius Stensland, Oddmund Nordgård, Ragnhild Sørum Falk, Randi R. Mathiesen, Hege G. Russnes, Jon Amund Kyte, Bjørn Naume
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Wiley 2025-07-01
سلاسل:	Molecular Oncology
الموضوعات:	breast cancer circulating tumor cells immune checkpoint inhibitors liquid biopsy
الوصول للمادة أونلاين:	https://doi.org/10.1002/1878-0261.13675
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!